Marshall Nathaniel S, Wong Keith K H, Liu Peter Y, Cullen Stewart R J, Knuiman Matthew W, Grunstein Ronald R
Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.
Sleep. 2008 Aug;31(8):1079-85.
Previously published cohort studies in clinical populations have suggested that obstructive sleep apnea (OSA) is a risk factor for mortality associated with cardiovascular disease. However, it is unknown whether sleep apnea is an independent risk factor for all-cause mortality in a community-based sample free from clinical referral bias.
Residents of the Western Australian town of Busselton underwent investigation with a home sleep apnea monitoring device (MESAM IV). OSA was quantified via the respiratory disturbance index (RDI). Mortality status was determined in 397/400 participants (99.3%) after up to 14 years (mean follow-up 13.4 years) by data matching with the Australian National Death Index and the Western Australian Death Register. Univariate analyses and multivariate Cox proportional hazards modelling were used to ascertain the association between sleep apnea and mortality after adjustment for age, gender, body mass index, mean arterial pressure, total cholesterol, high-density lipoprotein cholesterol, diabetes, and medically diagnosed angina in those free from heart attack or stroke at baseline (n = 380).
Among the 380 participants, 18 had moderate-severe OSA (RDI > or = 15/hr, 6 deaths) and 77 had mild OSA(RDI 5 to < 15/hr, 5 deaths). Moderate-to-severe OSA was independently associated with greater risk of all-cause mortality (fully adjusted hazard ratio [HR] = 6.24, 95% CL 2.01, 19.39) than non-OSA (n = 285, 22 deaths). Mild OSA (RDI 5 to < 15/hr) was not an independent risk factor for higher mortality (HR = 0.47, 95% CL 0.17, 1.29).
Moderate-to-severe sleep apnea is independently associated with a large increased risk of all-cause mortality in this community-based sample.
先前发表的针对临床人群的队列研究表明,阻塞性睡眠呼吸暂停(OSA)是心血管疾病相关死亡率的一个危险因素。然而,在一个无临床转诊偏倚的社区样本中,睡眠呼吸暂停是否是全因死亡率的独立危险因素尚不清楚。
西澳大利亚州巴瑟尔顿镇的居民使用家用睡眠呼吸暂停监测设备(MESAM IV)进行了调查。通过呼吸紊乱指数(RDI)对OSA进行量化。通过与澳大利亚国家死亡指数和西澳大利亚死亡登记册进行数据匹配,在397/400名参与者(99.3%)中确定了长达14年(平均随访13.4年)后的死亡状况。单因素分析和多因素Cox比例风险模型用于确定在基线时无心脏病发作或中风的人群(n = 380)中,调整年龄、性别、体重指数、平均动脉压、总胆固醇、高密度脂蛋白胆固醇、糖尿病和医学诊断的心绞痛后,睡眠呼吸暂停与死亡率之间的关联。
在380名参与者中,18人患有中度至重度OSA(RDI≥15/小时,6人死亡),77人患有轻度OSA(RDI 5至<15/小时,5人死亡)。与无OSA者(n = 285,22人死亡)相比,中度至重度OSA与全因死亡率风险增加独立相关(完全调整后的风险比[HR] = 6.24,95%置信区间2.01,19.39)。轻度OSA(RDI 5至<15/小时)不是死亡率升高的独立危险因素(HR = 0.47,95%置信区间0.17,1.29)。
在这个基于社区的样本中,中度至重度睡眠呼吸暂停与全因死亡率大幅增加独立相关。